Malathi, D.C., Janakiraman, K., Thangavelu, S.V.A. and Ravichandran, D. 2026. Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation. International Journal of Basic & Clinical Pharmacology. 15, 5 (Aug. 2026), 1126–1134. DOI:https://doi.org/10.18203/2319-2003.ijbcp20262890.